Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells
批准号:
8463141
负责人:
Aron Eliot Lukacher
金额:
$28.95万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2015-04-30
关键词:
AcuteAddressAffectAllogenicAmino AcidsAntigensAntiviral AgentsAvidityBacteriaBacterial InfectionsC57BL/6 MouseCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCapsid ProteinsCellsCellular ImmunityDataElementsEmigrantEvolutionFamilyFunctional disorderGenerationsGenesGenetic PolymorphismGoalsHaplotypesHealthHost DefenseImmunityImmunologic MonitoringInfectionInterferonsInterleukin-2InterventionLigandsMaintenanceMediatingModelingMouse StrainsMusOligopeptidesOncogenicPathway interactionsPeptidesPhasePhenotypePolyomavirusProductionReagentResistanceSystemT cell responseT-LymphocyteTNF geneTestingThymic epithelial cellViralViral Load resultViral VaccinesVirusVirus Diseasesbasecytokinedefined contributionfunctional disabilityinsightmembermicroorganism antigenmouse modelnovelpathogenthymocytetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Immunosurveillance for intracellular pathogens is primarily mediated by conventional TCR¿¿ CD8 T
lymphocytes that recognize pathogen-derived oligopeptides presented by the highly polymorphic "classical" or
MHC class Ia molecules. Yet, there is growing appreciation that these oligomorphic "nonclassical" or MHC
class Ib molecules may also present pathogen-derived antigens. Evidence to date, however, has suggested
that MHC-Ib-restricted CD8 T cell-mediated immunity is relegated to host defense against intracellular bacterial
infections. Using the mouse polyoma virus (PyV) model, we recently discovered that mice lacking MHC class
Ia molecules but retaining MHC class Ib molecules (i.e., Kb-/-Db-/- mice) are as resistant as their wild type
counterparts to the oncogeneic potential of this virus, efficiently control acute and persistent phases of
infection, and do so in a CD8¿¿ T cell-dependent manner. We identified the viral peptide and its MHC class
Ib-restricting molecule, constructed MHC-I tetrameric reagents, and tracked the evolution, functional integrity,
and maintenance of these novel unconventional CD8 T cells throughout the course of PyV infection.
Importantly, we determined that these antiviral CD8 T cells confer protection against PyV infection, and
constitute a previously unappreciated component of the antiviral CD8 T cell repertoire. Our new data thus
provides the first evidence for a defined MHC class Ib-restricted antiviral CD8 T cell response that contributes
to host defense. The overall goal of this application is to use the mouse PyV infection system to
comprehensively define the requirements for eliciting these unconventional CD8 T cells, and to apply insights
from these studies to evaluate candidate interventions to promote recruitment of antiviral CD8 T cells across
MHC class Ia allogeneic barriers. Three Specific Aims are proposed: (1) to define the requirements for
selection and maintenance of PyV-specific, MHC class Ib-restricted CD8 T cells; (2) to investigate
mechanism(s) to explain the finding that the majority of these T cells are functionally compromised; and (3) to
define the contributions of CD4 T cells and select costimulatory pathways in generating and maintaining
functional anti-PyV MHC class Ib-restricted CD8 T cells in order to promote control of PyV infection in mice of
MHC-Ia allogeneic strains.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.
肽免疫在 MHC ia 类同种异体小鼠中引发多瘤病毒特异性 MHC ib 类限制性 CD8 T 细胞。
DOI:
10.1089/vim.2012.0052
发表时间:
2013
期刊:
Viral immunology
影响因子:
2.2
作者:
[Hofstetter,AmeliaR, Evavold,BrianD, Lukacher,AronE]
通讯作者:
Lukacher,AronE
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity
-
批准号:10785321
-
项目类别:
-
资助金额:$8.68万
-
财政年份:2022
-
负责人:Aron Eliot Lukacher
-
依托单位:
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity
-
批准号:10449608
-
项目类别:
-
资助金额:$59.07万
-
财政年份:2022
-
负责人:Aron Eliot Lukacher
-
依托单位:
Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity
-
批准号:10610484
-
项目类别:
-
资助金额:$89.66万
-
财政年份:2022
-
负责人:Aron Eliot Lukacher
-
依托单位:
Defining Early Stages of Polyomavirus CNS Pathogenesis and Immunity
-
批准号:10365345
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2016
-
负责人:Aron Eliot Lukacher
-
依托单位:
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination
-
批准号:9185385
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2016
-
负责人:Aron Eliot Lukacher
-
依托单位:
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
-
批准号:8853962
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2014
-
负责人:Aron Eliot Lukacher
-
依托单位:
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
-
批准号:9920216
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:Aron Eliot Lukacher
-
依托单位:
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
-
批准号:9244865
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2014
-
负责人:Aron Eliot Lukacher
-
依托单位:
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
-
批准号:10133156
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2014
-
负责人:Aron Eliot Lukacher
-
依托单位:
T-cell immunity to polyomavirus infection
-
批准号:8687581
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:Aron Eliot Lukacher
-
依托单位:
T-cell immunity to polyomavirus infection
-
批准号:8515330
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2012
-
负责人:Aron Eliot Lukacher
-
依托单位:
T-cell immunity to polyomavirus infection
-
批准号:8371616
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:Aron Eliot Lukacher
-
依托单位:
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells
-
批准号:7729846
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2009
-
负责人:Aron Eliot Lukacher
-
依托单位:
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells
-
批准号:8063586
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2009
-
负责人:Aron Eliot Lukacher
-
依托单位:
Analysis of MHC Class Ib-Restricted Polyoma Virus-Specific CD8 T Cells
-
批准号:8243570
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2009
-
负责人:Aron Eliot Lukacher
-
依托单位:
Antiviral Therapy for Polyomavirus Infection
-
批准号:7233933
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2007
-
负责人:Aron Eliot Lukacher
-
依托单位:
Antiviral Therapy for Polyomavirus Infection
-
批准号:7350913
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2007
-
负责人:Aron Eliot Lukacher
-
依托单位:
Regulation of Polyoma Virus-Specific CD8+ T Cells
-
批准号:7226030
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2003
-
负责人:Aron Eliot Lukacher
-
依托单位:
Regulation of Polyoma Virus-Specific CD8+ T Cells
-
批准号:7060901
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2003
-
负责人:Aron Eliot Lukacher
-
依托单位:
Regulation of Polyoma Virus-Specific CD8+ T Cells
-
批准号:6888503
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2003
-
负责人:Aron Eliot Lukacher
-
依托单位:
海外基金